About GCNI

Our People

Biography

Ho Ko, Owen holds degrees in medical sciences and clinical medicine (BMedSc, MBChB) from CUHK, and completed his PhD in neuroscience at University College London with Tom Mrsic-Flogel. Owen’s early career focused on revealing fundamental principles of neural circuit organization. His doctoral work provided key insights into how neural circuits function and emerge, particularly in the context of visual processing. Transitioning from a systems neuroscientist to a clinician-scientist, his current research spans multiple areas of basic and translational neuroscience. His lab’s research program emphasizes the development of translational approaches that bridge basic neuroscience research with clinical applications in aging-related neurological disorders. Notable contributions include the identification of potential therapeutic approaches targeting the aging process for cerebrovascular disorders, and the development of new brain imaging techniques. His recent work on therapeutic strategies for cerebral small vessel disease has progressed from laboratory findings to an ongoing clinical trial.

Owen KO

Director, Gerald Choa Neuroscience Institute

Assistant Dean (Research), Faculty of Medicine

Associate Professor, Department of Medicine and Therapeutics

Research Interests

  • Gliovascular dysfunction and therapeutic targeting in aging and neurodegeneration
  • Neural circuits mediating sensorimotor behaviors and their dysfunction in aging
  • Imaging methods development for systems and translational neuroscience

Awards

  • 2023     Fellow (Life Science), Asian Young Scientist Fellowship, Future Science Awards Foundation
  • 2022     Sir David Todd Lectureship, Hong Kong College of Physicians
  • 2021     Awardee, Excellent Young Scientists Fund (Hong Kong and Macau), National Natural Science Foundation of China
  • 2020     Croucher Innovation Award, Croucher Foundation

Selected publications

  1. Functional and multi-omic aging rejuvenation with GLP-1R agonism. Huang J, Kwok AJ, Li JCY, Chiu CLH, Ip BYM, Tung LY, Zheng X, Chow HT, Lo MPS, Li Z, Chan RCH, Lin N, Wang Z, Wang M, Yan LYC, Chan DCW, Wu WKK, Chow HM, Lin WJ, Tang Y, Ng BWL, Wong SH, Leung TW, Mok VCT, Ko H. bioRxiv. doi: 10.1101/2024.05.06.592653
  1. An optofluidic platform for interrogating chemosensory behavior and brainwide neural representation. Sy SKH, Chan DCW, Chan RCH, Lyu J, Li Z, Wong KKY, Choi CHJ, Mok VCT, Lai HM, Randlett O, Hu Y, Ko H. Nature Communications. 2023 Jan 14;14(1):227.
  1. Antibody stabilization for thermally accelerated deep immunostaining. Lai HM, Tang Y, Lau ZYH, Campbell RAA, Yau JCN, Chan DCW, Wong HKT, Yan LYC, Wu WKK, Wong SH, Kwok KW, Wing YK, Ng HK, Mrsic-Flogel TD, Mok VCT, Chan JYK, Ko H. Nature Methods. 2022 Sep 1;19(9):1137-1146.
  1. Systemic GLP-1R agonist treatment reverses mouse glial and neurovascular cell transcriptomic aging signatures in a genome-wide manner. Li Z, Chen X, Vong JSL, Zhao L, Huang J, Yan LYC, Ip B, Wing YK, Lai HM, Mok VCT, Ko H. Communications Biology. 2021 Jun 2;4(1):656.
  1. Pharmacologically reversible zonation-dependent endothelial cell transcriptomic changes with neurodegenerative disease associations in the aged brain. Zhao L, Li Z, Vong JSL, Chen X, Lai HM, Yan LYC, Huang J, Sy SKH, Tian X, Huang Y, Chan HYE, So HC, Ng WL, Tang Y, Lin WJ, Mok VCT, Ko H. Nature Communications. 2020 Sep 4;11(1):4413.